Article Text
Therapeutics/Prevention
Randomised controlled trial
Trimethoprim-sulfamethoxazole monotherapy should not be used for treatment of severe methicillin-resistant Staphylococcus aureus infections
Statistics from Altmetric.com
Footnotes
Competing interests SH has received peer-reviewed research grants funded by Pfizer and B Braun, and is a member of the advisory boards of Destiny Pharma, bioMérieux, Novartis and DaVolterra.
Patient consent Obtained.
Provenance and peer review Commissioned; internally peer reviewed.